Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin

Por Lamorde, Mohammed, Byakika-Kibwika, Pauline, Okaba-Kayom, Violet, Ryan, Mairin, Coakley, Peter, Boffito, Marta, Namakula, Rhoda, Kalemeera, Francis, Colebunders, Robert, Back, David, Khoo, Saye, Merry, Concepta
Publicado em 2011

Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults

Por Byakika-Kibwika, Pauline, Lamorde, Mohammed, Lwabi, Peter, Nyakoojo, Wilson B., Okaba-Kayom, Violet, Mayanja-Kizza, Harriet, Boffito, Marta, Katabira, Elly, Back, David, Khoo, Saye, Merry, Concepta
Publicado em 2011

Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda

Por Mupere, Ezekiel, Babikako, Harriet M., Okaba-Kayom, Violet, Mutyaba, Robert B., Mwisaka, Milton Nasiero, Tenywa, Emmanuel, Lule, Albert, Aceng, Jane Ruth, Mpanga-Kaggwa, Flavia, Matseketse, David, Aga, Eresso
Publicado no PLoS One (2020)

Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1–Seropositive Ugandan Women

Por Lamorde, Mohammed, Byakika-Kibwika, Pauline, Okaba-Kayom, Violet, Flaherty, John P., Boffito, Marta, Namakula, Rhoda, Ryan, Mairin, Nakabiito, Clemensia, Back, David J., Khoo, Saye, Merry, Concepta, Scarsi, Kimberly K.
Publicado em 2010

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults

Por Byakika-Kibwika, Pauline, Lamorde, Mohammed, Okaba-Kayom, Violet, Mayanja-Kizza, Harriet, Katabira, Elly, Hanpithakpong, Warunee, Pakker, Nadine, Dorlo, Thomas P. C., Tarning, Joel, Lindegardh, Niklas, de Vries, Peter J., Back, David, Khoo, Saye, Merry, Concepta
Publicado em 2012